Caseous stomatitis caused by Pseudomonas aeruginosa in Boa constrictor amarali

Martins, Nathana Beatriz; Ferreira, Lucas Arthur Ricardo; Queiroz, Caroline Lopes; Buiatte, Ana Beatriz Garcez; Lima, Anna Monteiro Correia; Souza, Rafael Rocha de; Oliveira, Wilson Junior; Santos, André Luiz Quagliatto.
Acta sci. vet. (Online) ; 49(suppl.1): Pub. 615, Mar. 12, 2021. ilus
Artículo en Inglés | VETINDEX | ID: vti-30675

Documentos relacionados

  1. Caseous stomatitis caused by Pseudomonas aeruginosa in Boa constrictor amarali
  2. D-histidine combated biofilm formation and enhanced the effect of amikacin against Pseudomonas aeruginosa in vitro.
  3. Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
  4. The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa.
  5. Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa.
  6. Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection Model.
  7. Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings.
  8. Murepavadin promotes the killing efficacies of aminoglycoside antibiotics against <i>Pseudomonas aeruginosa</i> by enhancing membrane potential.
  9. A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve.
  10. HOCl-producing electrochemical bandage for treating <i>Pseudomonas aeruginosa</i>-infected murine wounds.